Cooper Companies | COO - Equity Capital And Reserves

Stock Price
64.34
Daily Change
-0.08 -0.12%
Monthly
-7.17%
Yearly
-21.39%
Q2 Forecast
63.04

Cooper Companies reported $8.36B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Abbott USD 52.13B 1.3B Dec/2025
Align Technology USD 3.96B 44.68M Sep/2025
AtriCure USD 491.94M 15.43M Dec/2025
Avanos Medical USD 778.2M 200K Dec/2025
Bausch Health Companies USD -554M 910M Dec/2025
Baxter International USD 6.13B 1.11B Dec/2025
Bayer EUR 25.95B 3.75B Dec/2025
Becton, Dickinson and Co. USD 25.28B 108M Dec/2025
Boston Scientific USD 24.23B 1.58B Dec/2025
Cooper Companies USD 8.36B 124.7M Dec/2025
Dentsply International USD 1.34B 139M Dec/2025
Dexcom USD 2.75B 19.9M Dec/2025
Edwards Lifesciences USD 10.34B 132.6M Dec/2025
Globus Medical USD 4.57B 174.42M Dec/2025
Haemonetics USD 911.45M 62.28M Dec/2025
Inogen USD 197.18M 2.32M Sep/2025
Insulet USD 1.52B 131.1M Dec/2025
Integra LifeSciences USD 1.04B 5.89M Dec/2025
Intuitive Surgical USD 17.47B 349.5M Mar/2026
J&J USD 81.19B 358M Mar/2026
Medtronic USD 48.99B 128M Dec/2025
Merit Medical Systems USD 1.58B 54.9M Dec/2025
Novartis USD 46.13B 1.8B Dec/2025
ResMed USD 6.32B 199.61M Dec/2025
STAAR Surgical USD 344.18M 9.6M Dec/2025
Steris USD 7.15B 145.4M Dec/2025
Stryker USD 21.78B 594M Sep/2025
Tandem Diabetes Care USD 155.17M 22.2M Dec/2025
Teleflex USD 3.12B 697.09M Dec/2025
Utah Medical Products USD 119.27M 1.02M Dec/2025
Zimmer Biomet Holdings USD 12.7B 68.3M Dec/2025